#
Title
1

Navigating the Impact of Preservatives in Ophthalmic Medications: Insights From Dr. Robert J. Noecker

2

Enhancing Patient Satisfaction through BAK-Free Solutions: Dr. Miriam Kolko's Vision for Preservative-Free Eye Care

3

Unveiling the Paradox: BAK's Role in American Pharmaceuticals With Dr. Nate Radcliffe

4

The European Approach to Preservative-Free Pharmaceuticals: A Conversation With Dr. Anton Hommer

5

Optics and Aberrations

6

Lens Lights Filters

7

Reducing Posterior Capsule Opacification

8

Innovations in Lens Technology and Visual Quality

9

Impact of Lens Materials on Optical Quality

10

Fundamentals of Lens Materials

11

Small-Aperture Technology

12

Understanding the Impact of Aperture Size on Vision

13

Best Practices on Communicating With Patients About Small-Aperture Technologies

14

Fundamentals of Small-Aperture Optics for Presbyopic Patients

15

Treating Meibomian Gland Dysfunction

16

Assessing Dry Eye Patients

17

Examining Lids: A Focus on Demodex Blepharitis and Blepharoptosis

18

Emergent Pharmaceutical Treatments for Dry Eye Diseases

19

Modern Interventional Treatments for Meibomian Gland Dysfunction

20

The Prevalence and Diagnosis of Meibomian Gland Dysfunction

21

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2

22

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 1

23

Integrating Presbyopia Drops Into Optometric Practice

24

The Future of Presbyopia With Drops

25

IOL Selection in Presbyopes With Comorbid Conditions (Part 2)

26

IOL Selection in Presbyopes With Comorbid Conditions (Part 1)

27

Managing Presbyopic Cataract Patients With Comorbid Conditions

28

Communicating With Today’s Cataract Patients About Their Presbyopia-Correcting IOL Options

29

Managing Different MIGS Patients

30

Early Intervention With MIGS

31

The Burden of Glaucoma: How Noncompliance Impacts Patients and Doctors

32

Integrating Presbyopia Drops into Your Practice

33

Keys to Effective Presbyopia Patient Conversations

34

The Newest Presbyopia Correcting IOLs

35

How to Bring Refractive Lens Exchange Into Your Practice

36

Identifying Refractive Lens Exchange Candidates

37

The Modern Refractive Lens Exchange Practice

38

Refractive Lens Exchange for Today’s Presbyopes

39

Premium IOL Selection for Hyperopic and Complex Cataract Patients

40

Incorporating Pharmaceutical Presbyopia Treatments Into Your Practice

41

Key Features of Pharmaceutical Presbyopia Treatments

42

Accessing That Leathery Posterior Plate - The Flip

43

Any Density Nucleus Horizontal Chop

44

Trenching to Transition to Horizontal Chop

45

Dense Cataract with Iridodialysis Repair

46

Managing a Traumatic Subluxed Cataract

47

The Challenge of Weak Zonules

48

Keratoconus and Blepharoptosis

49

Treating Meibomian Gland Dysfunction

50

Aqueous Dry Eye Treatment Recommendations

51

The Prevalence and Impact of Dry Eye Disease

52

ODs: Keratoconus Testing Consensus Roundtable: Part 3

53

ODs: Keratoconus Testing Consensus Roundtable: Part 2

54

ODs: Keratoconus Testing Consensus Roundtable: Part 1

55

MDs: Keratoconus Testing Consensus Roundtable: Part 3

56

MDs: Keratoconus Testing Consensus Roundtable: Part 2

57

MDs: Keratoconus Testing Consensus Roundtable: Part 1

58

Treating Flares vs. Chronic Dry Eye Disease

59

Diagnosing and Treating Dry Eye Flares

60

Definition and Impact of Dry Eye Flares

61

Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

62

Next-Generation Presbyopia-Correcting IOLs

63

Innovations in Pharmacological Treatments for Presbyopic Patients

64

Welcome to Eyecare Innovations Today